
Merck & Co Inc
MRKHealthcare|Drug Manufacturers - General|USA
$120.85
+0.00 (+0.00%)
DCF (FCF)
$75.40
Tangible Book
$1.76
Graham Number
$18.83
Earnings Power
$41.17
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
66786.47,
70401.38,
75329.93
],
"ebit_estimate": [
17746.19,
29396.62,
32105.45
],
"ebitda_estimate": [
21494.22,
32984.74,
36073.16
],
"net_income_estimate": [
12507.77,
24020.1,
26874.6
],
"per_share_eps_estimate": [
4.28,
8.8,
10.02
],
"eps_nri_estimate": [
5.04,
9.71,
10.86
],
"dividend_estimate": [
3.24,
3.55,
3.79
],
"book_value_per_share_estimate": [
28.09,
33.43,
33.99
],
"pretax_income_estimate": [
16438.64,
28861.69,
32126.87
],
"operating_cash_flow_per_share_estimate": [
6.19,
11.31,
12.82
],
"roa_estimate": [
12,
16.33,
17.5
],
"roe_estimate": [
27.16,
39.25,
36.84
],
"gross_margin_estimate": [
81.73,
81.93,
82.07
],
"operating_cash_flow_estimate": [
15381.38,
28125.36,
31877.98
],
"pettm_estimate": [
28.25,
13.73,
12.06
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "5.07",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 5.07,
"future_ebit_estimate_growth": 17.13,
"future_ebitda_estimate_growth": 12.3,
"future_dividend_estimate_growth": 5.36,
"future_net_income_estimate_growth": 19.88,
"future_pretax_income_estimate_growth": 20.07,
"future_book_value_per_share_estimate_growth": 17.14,
"future_roa_estimate_growth": 9.41,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 2.85,
"future_operating_cash_flow_per_share_estimate_growth": 29.82
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
15917.34,
16388.65,
17592.12,
16982.18,
16787.06,
17346.51,
18877.83,
18620.04
],
"ebit_estimate": [
-1923.03,
5764.42,
7333.47,
6561.61,
null,
null,
null,
null
],
"ebitda_estimate": [
-1589.96,
7564.46,
8281.56,
7026.5,
null,
null,
null,
null
],
"net_income_estimate": [
-3072.5,
4615.75,
5918.45,
5300.63,
5844,
6102,
7091,
6170
],
"per_share_eps_estimate": [
-1.68,
1.84,
2.16,
1.92,
null,
null,
null,
null
],
"eps_nri_estimate": [
-1.33,
1.81,
2.41,
2.14,
2.16,
2.27,
2.64,
2.48
],
"dividend_estimate": [
0.85,
0.85,
0.85,
0.85,
0.83,
0.83,
0.83,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-1882.22,
5168.16,
7123.6,
6305.35,
null,
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
-2.27,
2.37,
3.58,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
82.7,
81.37,
81.1,
80.31,
82.7,
82.7,
82.4,
82.3
],
"operating_cash_flow_estimate": [
-5630.79,
5891.82,
8899.88,
null,
null,
null,
null,
null
],
"pettm_estimate": [
28.52,
null,
null,
null,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "5.07",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 5.07,
"future_ebit_estimate_growth": 17.13,
"future_ebitda_estimate_growth": 12.3,
"future_dividend_estimate_growth": 5.36,
"future_net_income_estimate_growth": 19.88,
"future_pretax_income_estimate_growth": 20.07,
"future_book_value_per_share_estimate_growth": 17.14,
"future_roa_estimate_growth": 9.41,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 2.85,
"future_operating_cash_flow_per_share_estimate_growth": 29.82
}